Phase 3 OCEANIC-STROKE trial shows asundexian cut recurrent ischemic stroke
Phase 3 OCEANIC-STROKE data showed asundexian plus antiplatelet therapy reduced recurrent ischemic stroke versus placebo. Major bleeding rates were similar between groups.
Ischemic Stroke
DiseaseDisease Profile
Ischemic stroke occurs when blood flow to the brain is blocked, causing brain tissue injury from reduced oxygen delivery. It is the dominant stroke subtype and represents the majority of stroke burden in the United States.
- Category
- cerebrovascular disease
- Prevalence
- Ischemic strokes account for about 87% of all strokes.
Related News
Factor XIa Inhibitor Reduces Stroke Recurrence Without Increasing Bleeding Risk in Phase 3 Trial
The phase 3 OCEANIC-STROKE trial of 12,327 patients showed asundexian, an oral Factor XIa inhibitor, reduced ischemic stroke recurrence by 26% when added to standard antiplatelet therapy, with no increase in major bleeding events.
Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol in Phase 3 Trial
Enlicitide decanoate demonstrated efficacy in reducing LDL cholesterol levels compared to placebo in patients with atherosclerotic cardiovascular disease history or risk, according to phase 3 CORALreef Lipids trial data.
Related Clinical Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07600996 |
A Prospective Observational Study of Cerebrospinal Fluid Mitochondrial Biomarkers Measured by Flow Cytometry in Patients With Ischemic Stroke and Alzheimer Disease Controls |
RECRUITING | |
| NCT07592962 |
Whole-life Investigation of Lishui Longevity |
RECRUITING | |
| NCT07584681 |
Connectomic Alterations Following Acute Ischemic Stroke in the MCA Territory |
NOT_YET_RECRUITING | NA |
| NCT07577713 |
Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients |
NOT_YET_RECRUITING | |
| NCT07575984 |
Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke |
RECRUITING | PHASE4 |
| NCT07566598 |
Measuring Absolute Brain Flow and Brain Microcirculation Resistance by Continuous Thermodilution |
RECRUITING | NA |
| NCT07553650 |
Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE) |
NOT_YET_RECRUITING | |
| NCT07553416 |
Prospective, Randomized, Parallel-Controlled Study of Brain Computer Interface Integrated Robotic Mirror Therapy for Post-Stroke Upper Limb Motor Function Disorder |
NOT_YET_RECRUITING | NA |
| NCT07520630 |
Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke |
NOT_YET_RECRUITING | NA |
| NCT07511543 |
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy |
NOT_YET_RECRUITING | PHASE2 |